A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of Prograf extended
release(XL) plus MMF with Prograf plus MMF and steroid withdrawal in de novo Liver transplant
recipients